Combination with albumin, in particular for treating a cartilage defect
A combination comprising, spatially separate from one another, a first component and a second component, where the first component comprises crosslinkable albumin and the second component comprises a polymer, wherein non-terminal monomer units of the polymer comprise at least partially, more particu...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
20.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A combination comprising, spatially separate from one another, a first component and a second component, where the first component comprises crosslinkable albumin and the second component comprises a polymer, wherein non-terminal monomer units of the polymer comprise at least partially, more particularly only partially, an albumin-crosslinking group. Additionally disclosed is a reaction product obtainable by means of the combination, to a medical device, to a medicinal product for innovative therapies, to a kit, to a discharge apparatus, and to a functionalized hyaluronic acid. |
---|---|
Bibliography: | Application Number: US201716329647 |